Editorial: PROTACs: Targeted therapies for cancer treatment
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2023.1102721/full |
_version_ | 1811173216395198464 |
---|---|
author | Sobia Tabassum |
author_facet | Sobia Tabassum |
author_sort | Sobia Tabassum |
collection | DOAJ |
first_indexed | 2024-04-10T17:43:13Z |
format | Article |
id | doaj.art-68968f0fe231466bae1d48d4159d7bcc |
institution | Directory Open Access Journal |
issn | 2296-634X |
language | English |
last_indexed | 2024-04-10T17:43:13Z |
publishDate | 2023-02-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Cell and Developmental Biology |
spelling | doaj.art-68968f0fe231466bae1d48d4159d7bcc2023-02-03T07:04:31ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2023-02-011110.3389/fcell.2023.11027211102721Editorial: PROTACs: Targeted therapies for cancer treatmentSobia Tabassumhttps://www.frontiersin.org/articles/10.3389/fcell.2023.1102721/fullResearch Topicproteolysis-targeting chimeric molecule (PROTAC)cancer treatmentstate of artcutting edge technology |
spellingShingle | Sobia Tabassum Editorial: PROTACs: Targeted therapies for cancer treatment Frontiers in Cell and Developmental Biology Research Topic proteolysis-targeting chimeric molecule (PROTAC) cancer treatment state of art cutting edge technology |
title | Editorial: PROTACs: Targeted therapies for cancer treatment |
title_full | Editorial: PROTACs: Targeted therapies for cancer treatment |
title_fullStr | Editorial: PROTACs: Targeted therapies for cancer treatment |
title_full_unstemmed | Editorial: PROTACs: Targeted therapies for cancer treatment |
title_short | Editorial: PROTACs: Targeted therapies for cancer treatment |
title_sort | editorial protacs targeted therapies for cancer treatment |
topic | Research Topic proteolysis-targeting chimeric molecule (PROTAC) cancer treatment state of art cutting edge technology |
url | https://www.frontiersin.org/articles/10.3389/fcell.2023.1102721/full |
work_keys_str_mv | AT sobiatabassum editorialprotacstargetedtherapiesforcancertreatment |